Targepeutics

Private

Hummelstown, PennsylvaniaHealthcare & Life Scienceshttps://targepeutics.com/

Last Round

Seed

Jul 24, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Targepeutics is a biopharmaceutical company that develops selective molecularly targeted immunotoxin therapies for the treatment of aggressive brain cancers, including glioblastoma and diffuse midline glioma.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

immunotoxinglioblastomabiopharmaceuticaltargeted therapydiffuse midline gliomaDMGGBMprecision medicinebiologic therapycancer drug developmentoncologyclinical trialsdrug discoverycancer biotechbrain cancer treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Targepeutics Comps

Public and private peers based on sector, stage, and business model.

Targepeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Targepeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jul 24, 2025
Grant	Sep 12, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Sil Lutkewitte

Chief Executive Officer

Executive Team

Targepeutics Investors

Notable investors and investment history

Targepeutics investors
Investor	Rounds
National Cancer Institute	Grant
Yuvaan Tiwari Foundation	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 7, 2026
Monthly visitors increased 102% MoM.

View all signals

Targepeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Targepeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Targepeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHummelstown, Pennsylvania

Employee Range5

Year Founded2000

Last FundingJul 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.